Night Shift Work Linked to Increased Risk of Diabetes and Obesity
Washington State University Study
Researchers from Washington State University, USA, have unveiled findings indicating that as few as three consecutive night shifts may heighten the risk of developing diseases such as diabetes, obesity, and other metabolic disorders. The study highlights how night shifts disrupt the body’s protein rhythms associated with blood glucose regulation, energy metabolism, and inflammation, potentially exacerbating chronic metabolic conditions.
New Delhi: A recent study suggests that just three consecutive night shifts could significantly elevate the likelihood of developing various diseases, including diabetes and obesity, according to researchers from Washington State University, USA. The study reveals how night shifts disrupt the body’s protein rhythms responsible for regulating blood glucose levels.
Published in the Journal of Proteome Research, the study emphasizes the significance of the body’s “master biological clock,” which governs daily rhythms. Disruption of this clock due to night shifts can induce stress, leading to long-term health consequences, as explained by Professor Hans Van Dongen.

Furthermore, Van Dongen notes that even a brief period of night shift work can disrupt these rhythms, increasing health risks. This suggests the potential for early intervention to mitigate the risks of diabetes and obesity.
Using blood samples, the research team identified specific proteins within blood-based immune cells, some of which closely followed the master biological clock’s rhythms without alteration during night shifts. However, the majority of proteins exhibited changes. Analysis revealed a significant disruption in glucose regulation rhythms among night-shift workers, along with desynchronization in processes related to insulin production and sensitivity.

Moreover, previous studies have highlighted the detrimental impact of shift work on blood pressure, increasing the risk of cardiovascular diseases such as heart disease and stroke, particularly among night shift workers.
This week’s popular products
-
Original price was: ₹1,199.00.₹699.00Current price is: ₹699.00.
Almannat Perfume & Attar Combo – One Blue|Hajr Al Aswad|Blu Musk|Choco Musc|Dobe|Leman|Ameerul Oud|Paeneapple|Whyte Rose|Luvely|Deeds|Choklate
-
Original price was: ₹1,199.00.₹699.00Current price is: ₹699.00.
Almannat Perfume & Attar Combo – Musc Safi|Whyte Rose|Blu Musk|Whyte Stone|Whyte Amber|Paeneapple|Shilk|Musc|Dobe|Jaghuar|Kashmiry Gulaab|Labbake
-
Original price was: ₹1,199.00.₹699.00Current price is: ₹699.00.
Almannat Perfume & Attar Combo –Mookhallat Golden|Secred Love|Blu Musk|Shanaya Golden|Dobe|Blue Roses|Whyte London|Black Stone|Mogra|Whyte Oud|Roze|Saduf
-
1002 Nights
Original price was: ₹698.00.₹399.00Current price is: ₹399.00. -
1002 Nights
Original price was: ₹949.00.₹549.00Current price is: ₹549.00. -
Aaseel
Original price was: ₹859.00.₹459.00Current price is: ₹459.00.
-
Midnight Omen by Trudon 2025 NEW! NEW!
Views: 644 Heya Posse! New stuff from Trudon is always cue for celebrations. While not all of their offerings suit my taste, they are all nicely crafted and often smell as expensive as they are. Midnight Omen is not groundbreaking but it does that scratchy woods and ambers in a very wearable and non combative…
-
Try Something New! Avon Perfect Nonsense Banana Oud
Views: 54 Affordable and playful? Don’t mind if I do. Avon are messing about in the lab again and having serendipitous results, thanks to perfumers Adriana Medina and Amélie Jacquin. You may recall Avon Perfect Nonsense Bamboozle Cocktail, Choco Tuberose, Ginger Blaze and Peppery Peaches, which I reviewed earlier this year. Well, make way for…
-
Serge Lutens Le Participe Passé
Views: 19 Expecting a new rubbish bin and an outside food recycling bin from the council within the next couple of weeks. Am ludicrously excited about this. Do these sorts of things make you cheerful? I booked tickets for the farm shop’s annual pumpkin festival – for Halloween (yes, the 31st of October – my…





